References
- Alexander, S. P., Mathie, A. and Peters, J. A. (2008) Guide to receptors and channels (GRAC). Br. J. Pharmacol. 153, S1-209. https://doi.org/10.1038/sj.bjp.0707746
- Atwood, B. K., Lee, D., Straiker, A., Widlanski, T. S. and Mackie, K. (2011) CP47, 497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB1 cannabinoid receptor agonists. Eur. J. Pharmacol. 659, 139-145. https://doi.org/10.1016/j.ejphar.2011.01.066
- Aung, M. M., Griffi n, G., Huffman, J. W., Wu, M. J., Keel, C., Yang, B., Showalter, V. M., Abood, M. E. and Martin, B. R. (2000) Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding. Drug Alcohol Depend. 60, 133-140. https://doi.org/10.1016/S0376-8716(99)00152-0
- Auwarter, V., Dresen, S., Weinmann, W., Muller, M., Puts, M. and Ferreiros, N. (2009) 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 44, 832-837. https://doi.org/10.1002/jms.1558
- Bozarth, M. A. (1987) Conditioned place preference: A parametric analysis using systemic heroin injections. In: Methods of assessing the reinforcing properties of abused drugs. (M. A. Bozarth, Ed), pp 241-273. Springer-Verlag, New York.
- Carlezon, W. A. and Chartoff, E. H. (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat. Protoc. 2, 2987-2995. https://doi.org/10.1038/nprot.2007.441
- Chaperon, F. and Thiebot, M. H. (1999) Behavioral effects of cannabinoid agents in animals. Crit. Rev. Neurobiol. 13, 243-281. https://doi.org/10.1615/CritRevNeurobiol.v13.i3.20
- Corcoran, M. E. and Amit, Z. (1974) Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation. Psychopharmacologia 35, 129-147. https://doi.org/10.1007/BF00429580
- Devane, W. A., Dysarz, F. A. 3rd, Johnson, M. R., Melvin, L. S. and Howlett, A. C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 605-613.
- Gaoni, Y. and Mechoulam, R. (1964) Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646-1647. https://doi.org/10.1021/ja01062a046
- ElSohly, M. A., Gul, W., Wanas, A. S. and Radwan, M. M. (2014) Synthetic Cannabinoids: Analysis and Metabolites. Life Sci. 97, 78-90. https://doi.org/10.1016/j.lfs.2013.12.212
- Hsieh, C., Brown, S., Derleth, C. and Mackie, K. (1999) Internalization and recycling of the CB1 cannabinoid receptor. J. Neurochem. 73, 493-501.
- Jin, W., Brown, S., Roche, J. P., Hsieh, C., Celver, J. P., Kovoor, A., Chavkin, C. and Mackie, K. (1999) Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J. Neurosci. 19, 3773-3780.
- Leite, J. R. and Carlini, E. A. (1974) Failure to obtain 'cannabis-directed behavior' and abstinence syndrome in rats chronically treated with Cannabis sativa extracts. Psychopharmacologia 36, 133-145. https://doi.org/10.1007/BF00421785
- Mackie, K. (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. Exp. Pharmacol. 168, 299-325. https://doi.org/10.1007/3-540-26573-2_10
- Mucha, R. F., Van Der Kooy, D., O'Shaughnessy, M. and Bucenieks, P. (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res. 243, 91-105. https://doi.org/10.1016/0006-8993(82)91123-4
- Narita, M., Akai, H., Nagumo, Y., Sunagawa, N., Hasebe, K., Nagase, H., Kita, T., Hara, C. and Suzuki, T. (2004) Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats. Neuroscience 127, 941-948. https://doi.org/10.1016/j.neuroscience.2004.06.017
- Roche, J. P., Bounds, S., Brown, S. and Mackie, K. (1999) A mutation in the second transmembrane region of the CB1 receptor selectively disrupts G protein signaling and prevents receptor internalization. Mol. Pharmacol. 56, 611-618. https://doi.org/10.1124/mol.56.3.611
- Showalter, V. M., Compton, D. R., Martin, B. R. and Abood, M. E. (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identifi cation of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278, 989-999.
- Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N. and Goda, Y. (2009a) Identifi cation of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol. 27, 61-66. https://doi.org/10.1007/s11419-009-0069-y
- Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N., Haishima, Y. and Goda, Y. (2009b) Identifi cation of a cannabinoid analog as a new type of designer drug in a herbal product. Chem. Pharm. Bull. 57, 439-441. https://doi.org/10.1248/cpb.57.439
- Valjent, E. and Maldonado, R. (2000) A behavioural model to reveal place preference to delta9-tetrahydrocannabinol in mice. Psychopharmacology 147, 436-438. https://doi.org/10.1007/s002130050013
- Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D. and Davison, J. S. (2005) Identifi cation and functional characterization of brainstem cannabinoid CB2 receptors. Science 310, 329-332. https://doi.org/10.1126/science.1115740
- Wu, D. F., Yang, L. Q., Goschke, A., Stumm, R., Brandenburg, L. S., Liang, Y. J., Hollt, V. and Koch, T. (2008) Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. J. Neurochem. 104, 1132-1143. https://doi.org/10.1111/j.1471-4159.2007.05063.x
- Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S. R. and Wise, R. A. (2006) Two brain sites for cannabinoid reward. J. Neurosci. 26, 4901-4907. https://doi.org/10.1523/JNEUROSCI.3554-05.2006
Cited by
- The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity vol.22, pp.1, 2017, https://doi.org/10.1111/adb.12299
- Chemical characterization of synthetic cannabinoids by electrospray ionization FT-ICR mass spectrometry vol.266, 2016, https://doi.org/10.1016/j.forsciint.2016.07.007
- Les cannabinoïdes de synthèse : épidémiologie, modalités de consommations et effets cliniques vol.27, pp.1, 2015, https://doi.org/10.1016/j.toxac.2014.10.002
- Synthetic cannabinoids vol.28, pp.6, 2017, https://doi.org/10.1097/FBP.0000000000000323
- Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA vol.31, pp.6, 2017, https://doi.org/10.1177/0269881116684336
- Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats vol.233, pp.10, 2016, https://doi.org/10.1007/s00213-016-4237-6
- The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation 2016, https://doi.org/10.1111/adb.12472
- Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice vol.67, 2016, https://doi.org/10.1016/j.pnpbp.2016.01.007
- A synthetic cannabinoid JWH-210 reduces lymphoid organ weights and T-cell activator levels in mice via CB2 receptors 2017, https://doi.org/10.1007/s00210-017-1418-8
- Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210 vol.23, pp.6, 2015, https://doi.org/10.4062/biomolther.2015.057
- Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project vol.8, pp.10, 2016, https://doi.org/10.1002/dta.1936
- Synthetic cannabinoid, JWH-030, induces QT prolongation through hERG channel inhibition vol.5, pp.6, 2016, https://doi.org/10.1039/C6TX00259E
- Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health vol.8, 2017, https://doi.org/10.3389/fpsyt.2017.00156
- Old and new synthetic cannabinoids: lessons from animal models vol.50, pp.1, 2018, https://doi.org/10.1080/03602532.2018.1430824
- Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists vol.134, pp.1, 2014, https://doi.org/10.1016/j.neuropharm.2017.10.041
- Receptor Binding Affinities of Synthetic Cannabinoids Determined by Non-Isotopic Receptor Binding Assay vol.35, pp.1, 2019, https://doi.org/10.5487/tr.2019.35.1.037
- Receptor Binding Affinities of Synthetic Cannabinoids Determined by Non-Isotopic Receptor Binding Assay vol.35, pp.1, 2019, https://doi.org/10.5487/tr.2019.35.1.037
- Cannabinoid Receptor Type 1 Regulates Drug Reward Behavior via Glutamate Decarboxylase 67 Transcription vol.22, pp.19, 2014, https://doi.org/10.3390/ijms221910486